Research funding is another critical element that contributes to market uncertainty. Funding can come from government grants, private investments, or philanthropic organizations. Fluctuations in these funding sources can delay or accelerate the development of new treatments. For example, a sudden increase in funding for gene therapy could expedite its market entry, altering the competitive dynamics.
